Cargando…

Antibody dependent disease enhancement (ADE) after COVID-19 vaccination and beta glucans as a safer strategy in management

A potential risk associated with vaccines for COVID-19 is antibody-dependent disease enhancement (ADE) in which vaccine induced antibody mediated immune responses may lead to enhanced SARS CoV- 2 acquisition or increased disease severity. Though ADE has not been clinically demonstrated with any of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ikewaki, Nobunao, Kurosawa, Gene, Levy, Gary A., Preethy, Senthilkumar, Abraham, Samuel J.K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992059/ https://www.ncbi.nlm.nih.gov/pubmed/36906407 http://dx.doi.org/10.1016/j.vaccine.2023.03.005

Ejemplares similares

β-glucans: wide-spectrum immune-balancing food-supplement-based enteric (β-WIFE) vaccine adjuvant approach to COVID-19
por: Ikewaki, Nobunao, et al.
Publicado: (2021)

Hepatoprotective Effects of Aureobasidium pullulans Derived β 1,3–1,6 Glucans in a Murine Model of Non-alcoholic Steatohepatitis
por: Ikewaki, Nobunao, et al.
Publicado: (2022)

Improvement of behavioural pattern and alpha-synuclein levels in autism spectrum disorder after consumption of a beta-glucan food supplement in a randomised, parallel-group pilot clinical study
por: Raghavan, Kadalraja, et al.
Publicado: (2022)

Improvement of sleep and melatonin in children with autism spectrum disorder after β‐1,3/1,6‐glucan consumption: An open‐label prospective pilot clinical study
por: Raghavan, Kadalraja, et al.
Publicado: (2022)

Benefits of Gut Microbiota Reconstitution by Beta 1,3–1,6 Glucans in Subjects with Autism Spectrum Disorder and Other Neurodegenerative Diseases
por: Raghavan, Kadalraja, et al.
Publicado: (2023)

Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study
por: Raghavan, Kadalraja, et al.
Publicado: (2022)

Coagulopathy associated with COVID-19 – Perspectives & Preventive strategies using a biological response modifier Glucan
por: Ikewaki, Nobunao, et al.
Publicado: (2020)

Qualitative Evaluation of α-Synuclein: A Critical Step in Unravelling the Complexities of Autism Spectrum Disorder
por: Preethy, Senthilkumar, et al.
Publicado: (2022)

Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study
por: Raghavan, Kadalraja, et al.
Publicado: (2023)

Biological response modifier glucan through balancing of blood glucose may have a prophylactic potential in COVID-19 patients
por: Ikewaki, Nobunao, et al.
Publicado: (2020)

Corrigendum to “Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study” [IBRO Neurosci. Rep. 15 (2023), pp. 90–99]
por: Raghavan, Kadalraja, et al.
Publicado: (2023)

Potentials to alleviate coagulopathy and enhance microglial function of beta (β)- glucans, making them worth a clinical study for COVID-19's neurological sequalae
por: Raghavan, Kadalraja, et al.
Publicado: (2021)

Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential applications in human health and disease
por: Preethy, Senthilkumar, et al.
Publicado: (2022)

Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis
por: Preethy, Senthilkumar, et al.
Publicado: (2022)

Integrating the Synergy of the Gut Microbiome into Regenerative Medicine: Relevance to Neurological Disorders
por: Preethy, Senthilkumar, et al.
Publicado: (2022)

Beta 1,3-1,6 Glucans Produced by Two Novel Strains of Aureobasidium Pullulans Exert Immune and Metabolic Beneficial Effects in Healthy Middle-aged Japanese Men: Results of an Exploratory Randomized Control Study
por: Ikewaki, N., et al.
Publicado: (2023)

Role of Immune Dysregulation in Increased Mortality Among a Specific Subset of COVID-19 Patients and Immune-Enhancement Strategies for Combatting Through Nutritional Supplements
por: Rao, Kosagi-Sharaf, et al.
Publicado: (2020)

Commentary: Beyond “TRIM” Benefits of β-Glucan by Blood Glucose and Lipid Balancing Potentials in Its Defense Against COVID-19
por: Ikewaki, Nobunao, et al.
Publicado: (2021)

Resolution of fibrosis in mdx dystrophic mouse after oral consumption of N-163 strain of Aureobasidium pullulans produced β-glucan
por: Preethy, Senthilkumar, et al.
Publicado: (2023)

Out of the frying pan and into the fire? Due diligence warranted for ADE in COVID-19
por: Coish, Jeremia M., et al.
Publicado: (2020)

Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19
por: Karthik, Kumaragurubaran, et al.
Publicado: (2020)

Articular chondrocytes from osteoarthritic knee joints of elderly, in vitro expanded in thermo-reversible gelation polymer (TGP), exhibiting higher UEA-1 expression in lectin microarray
por: Katoh, Shojiro, et al.
Publicado: (2020)

Potential Effects of Nichi Glucan as a Food Supplement for Diabetes Mellitus and Hyperlipidemia: Preliminary Findings from the Study on Three Patients from India
por: Dedeepiya, Vidyasagar Devaprasad, et al.
Publicado: (2012)

High Frequency of AdeA, AdeB and AdeC Genes among Acinetobacter baumannii Isolates
por: RANJBAR, Reza, et al.
Publicado: (2020)

Antibody-Dependent Enhancement (ADE) and the role of complement system in disease pathogenesis
por: Thomas, Swapna, et al.
Publicado: (2022)

AdeR-AdeS mutations & overexpression of the AdeABC efflux system in ciprofloxacin-resistant Acinetobacter baumannii clinical isolates
por: Lari, Abdolaziz Rastegar, et al.
Publicado: (2018)

Production and Characterization of a Human Monoclonal Antibody Recognizing a New Antigen Expressed on Some Lymphoid Cells
por: Ikewaki, Nobunao, et al.
Publicado: (1990)

The ADE Display Application
por: Solero, Almudena
Publicado: (2003)

Antibody-Dependent Enhancement (ADE) of infection and its possible role in the pathogenesis of influenza
por: Dutry, Isabelle, et al.
Publicado: (2011)

Intrinsic ADE: The Dark Side of Antibody Dependent Enhancement During Dengue Infection
por: Narayan, Rohan, et al.
Publicado: (2020)

Theoretical Explanation for the Rarity of Antibody-Dependent Enhancement of Infection (ADE) in COVID-19
por: Boldova, Anna E., et al.
Publicado: (2022)

Evolving understanding of antibody-dependent enhancement (ADE) of SARS-CoV-2
por: Yang, Yalong, et al.
Publicado: (2022)

Better science for safer medicines: the human imperative
por: Archibald, Kathy, et al.
Publicado: (2018)

Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies
por: Ricke, Darrell O.
Publicado: (2021)

Evaluation of Antibiotic Resistance and adeABC, adeR, adeS Efflux Pump Genes among Foodborne and Clinical Acinetobacter spp. in Türkiye
por: Terkuran, Mevhibe, et al.
Publicado: (2022)

Safer Conception Strategies for HIV-Serodiscordant Couples: How Safe Is Safe Enough?
por: Ciaranello, Andrea L., et al.
Publicado: (2015)

Reversal of senescence-associated beta-galactosidase expression during in vitro three-dimensional tissue-engineering of human chondrocytes in a polymer scaffold
por: Katoh, Shojiro, et al.
Publicado: (2021)

Safer ventilation of the injured lung: one step closer
por: Marini, John J
Publicado: (2010)

Safer opioid distribution in response to the COVID-19 pandemic
por: Tyndall, Mark
Publicado: (2020)

Smallpox Still Haunts Scientists: Results of a Questionnaire-Based Inquiry on the Views of Health Care and Life Science Experts and Students on Preserving the Remaining Variola Virus Stocks
por: Srinivasan, Thangavelu, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3laskthtp8f59e09mgtt3cdr25